Source: AETC National Coordinating Resource Center
Published April 17, 2017

Four new HIV Meds Updates have been added to the AETC Program Blog ShareSpot. This series provides a summary about new information on antiretroviral drug treatment presented at CROI 2017. The series includes the following articles:

CROI 2017: Doravirine Noninferior to Darunavir + Ritonavir in Initial Treatment

CROI 2017: Bictegravir and Dolutegravir, Head-to-Head Comparison

CROI 2017: Dolutegravir in 2-Drug Simplification Studies

CROI 2017: Failure of Dolutegravir Monotherapy

Click here to read the latest posts, and to catch up on past ShareSpot stories.